Astellas Institute for Regenerative Medicine information
Subsidiary of Astellas Pharma
Astellas Institute for Regenerative Medicine
Company type
Subsidiary
Industry
Biotechnology
Founded
1994
Headquarters
Marlborough, MA
Products
Stem cell therapies for macular degeneration (human safety trial started in 2010[1]), retinis pigmentosa, glaucoma and corneal blindness[2]
Website
Official website
Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies with a focus on diseases that cause blindness. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated (ACT), which was renamed to Ocata Therapeutics in November 2014.[3] In February 2016 Ocata was acquired by Astellas for $379 million USD.
[4][5]
^
"Company seeks to test stem cells for blindness". Reuters. 2009-11-25.
^"Ocata website: Pipeline Overview". Archived from the original on 2015-01-09. Retrieved 2015-03-09.
^"Advanced Cell Technology Changes Name to Ocata Therapeutics". Ocata Therapeutics. 2014-11-14. Archived from the original on 2015-04-02. Retrieved 2015-04-25.
^"Astellas to acquire Ocata Therapeutics for $379M". GEN - Genetic Engineering and Biotechnology News. 2015-11-10. Retrieved 2020-04-29.
^"Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries - Feb 10, 2016". Astellas Pharma US, Inc. | News Room. Retrieved 2020-04-29.
and 9 Related for: Astellas Institute for Regenerative Medicine information
AstellasInstituteforRegenerativeMedicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies...
currently Head of Astellas Global RegenerativeMedicine, and Chief Scientific Officer of the AstellasInstituteforRegenerativeMedicine. He is an Adjunct...
pharmaceutical drugs, regenerativemedicine, stem cells, biologics manufacturing, magnetic tape data storage, optical films for flat-panel displays, optical...
Alliance forRegenerativeMedicine - Member organization. The alliance is an international advocacy organization supporting the development of regenerative medicines...
Archived from the original on 27 October 2020. Retrieved 21 September 2020. "Astellas' Audentes reports 3rd death in gene therapy trial". Fierce Biotech. 21...
regenerativemedicine to compensate for the shrinking digital camera market. Among Nikon's many notable product lines are Nikkor imaging lenses (for F-mount...
Bradway. CDC Foundation - Funding partner. Centre for Commercialization of RegenerativeMedicine (CCRM) - Industry partner. Council on Foreign Relations...
List of foreign aid to Ukraine during the Russo-Ukrainian War Fundraising for Ukraine during the 2022 Russian invasion of Ukraine Starlink satellite services...
Global Information